U.S. Fourth Circuit Court Rules North Carolina Can Ban Sale of FDA-Unapproved E-Cigarette Products

Jul.30.2025
U.S. Fourth Circuit Court Rules North Carolina Can Ban Sale of FDA-Unapproved E-Cigarette Products
The U.S. Fourth Circuit Court upheld North Carolina's right to ban the sale of FDA-unapproved e-cigarettes, rejecting an injunction request. Plaintiffs argued the state can't enforce FDA rules, but the state said halting the law would cause confusion. The case remains under review.

Key points:

 

·The court has ruled that the Fourth Circuit Court of Appeals in the United States has refused to issue an injunction, supporting North Carolina's ban on the sale of e-cigarettes. 

 

·The legal background is that North Carolina law prohibits the sale of e-cigarette products that have not been approved by the FDA, and this law went into effect at the end of June. 

 

·The plaintiffs, including the e-Cigarette Technology Association, argue that the state government does not have the authority to enforce FDA regulations, as this would encroach on federal powers. 

 

·The state government responded by stating that suspending the law would cause confusion, as stakeholders have already begun to comply with it. 

 

·The case is currently being heard at the Fourth Circuit Court of Appeals under case number 25-1745.

 


 

【2Firsts News Flash】According to a report by Law360 on July 29th, the U.S. Fourth Circuit Court of Appeals will not issue an injunction to block a North Carolina law that would prohibit the sale of e-cigarette products not approved by the U.S. Food and Drug Administration (FDA). Prior to this decision, stakeholders in the e-cigarette industry had appealed a lower court's ruling rejecting the same injunction.

 

In a notice filed on July 28th, the court denied the plaintiff's motion, led by the e-cigarette Technology Association, to challenge the 2024 bill in Federal Court. The law, which came into effect at the end of June, grants North Carolina tax officials the power to impose fines on retailers, wholesalers, and manufacturers of e-cigarettes that are sold without FDA authorization.

 

U.S. District Judge Richard E. Myers II denied their injunction request on June 27. In early July, the plaintiffs applied for an injunction to the Fourth Circuit Court of Appeals, arguing that states cannot enforce FDA regulations because it would infringe on federal powers. The state responded last week, stating that halting the law would cause chaos as stakeholders have already begun to comply with it.

 

The case number is 25-1745 and is being reviewed by the United States Fourth Circuit Court of Appeals.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Consultation opens for Tasmania’s Public Health Amendment Bill 2026
Consultation opens for Tasmania’s Public Health Amendment Bill 2026
Consultation opened on February 6, 2026 for the Public Health Amendment (Prohibited Tobacco and Other Products) Bill 2026. The Bill intends to address illicit trade in tobacco, nicotine pouches and e-cigarettes, which has increased significantly across Tasmania in recent years. It proposes changes to the Public Health Act 1997 to further protect the health of Tasmanians by reducing the sale and supply of illicit tobacco, vaping and other products, and to strengthen existing tobacco control laws.
Feb.06 by 2FIRSTS.ai
Special Report | China’s New Five-Year Plan Highlights “Health-First” Strategy, Providing Policy Context for Tobacco Sector
Special Report | China’s New Five-Year Plan Highlights “Health-First” Strategy, Providing Policy Context for Tobacco Sector
China’s 2026 “Two Sessions” reviewed the draft Outline of the 15th Five-Year Plan, which proposes implementing a health-first development strategy and strengthening the effectiveness of the Patriotic Health Campaign. Although the document does not address specific industries, this public-health governance framework provides a new policy context for observing the future regulation, product strategies, and market development of China’s tobacco and next-generation nicotine sectors.
Industry Insight
Mar.08
FDA Highlights Product Characterization as a Foundational Requirement in ENDS PMTA Reviews
FDA Highlights Product Characterization as a Foundational Requirement in ENDS PMTA Reviews
During its ongoing PMTA roundtable, FDA emphasized that product characterization is a foundational element in the review of electronic nicotine delivery systems (ENDS). The agency underscored the need for complete product identifying information, validation and verification of test methods on the specific product type, and the appropriate use of tobacco product master files (TPMFs) to support complex or proprietary ingredients in PMTA submissions.
Feb.10
Singapore New bill would raise maximum fines to S$200,000 for sellers and S$300,000 for smugglers
Singapore New bill would raise maximum fines to S$200,000 for sellers and S$300,000 for smugglers
A bill introduced in Singapore’s Parliament on Feb. 12 proposes major increases in penalties for vaping-related offences, including higher maximum fines for users, sellers and smugglers. The draft would also rename the current Tobacco (Control of Advertisements and Sale) Act as the Tobacco and Vaporisers Control Act.
Feb.28 by 2FIRSTS.ai
Product | Vaporesso lists Vibe SE 2 on official site, offering leather/plated versions and a 1,400mAh battery
Product | Vaporesso lists Vibe SE 2 on official site, offering leather/plated versions and a 1,400mAh battery
Vaporesso has recently listed the Vibe SE 2, a new device in its Vibe series, on the brand’s official website. The product is positioned as an entry-level MTL device and features a 1,400mAh built-in battery with Type-C 1A charging. It is available in two finishes—Leather and Plated—while listings on online retail channels show prices of around $17.99 and £22.99.
Jan.30 by 2FIRSTS.ai
California: Stiiizy hit with another lawsuit alleging high-THC vapes marketed to teens
California: Stiiizy hit with another lawsuit alleging high-THC vapes marketed to teens
A new lawsuit in California state court accuses Stiiizy Inc. of steering high-THC vape products toward teens through youth-appealing branding and weak age verification, alleging the plaintiff’s underage use was followed by cannabis-induced psychosis-related symptoms and significant personal harm.
Feb.06 by 2FIRSTS.ai